Changes in the epidemiology of thalassemia in North America: A new minority disease

Pediatrics

Volumn 116, Issue 6, 2005, Pages

  Vichinsky, Elliott P ^a   MacKlin, Eric A ^b   Waye, John S ^c   Lorey, Fred ^d   Olivieri, Nancy F ^e  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Demography; Epidemiology; Genotype; Minority disease; Phenotype; Survival; Thalassemia

Indexed keywords

HEMOGLOBIN E; HEMOGLOBIN H; IRON CHELATE;

ADOLESCENT; ADULT; AGING; ALLELE; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CANCER SURVIVAL; CHILD; CLINICAL RESEARCH; CONTROLLED STUDY; ETHNICITY; GENE MUTATION; GENE STRUCTURE; GENOTYPE; HEALTH CENTER; HEALTH SURVEY; HEMOGLOBINOPATHY; HETEROZYGOSITY; HUMAN; IMMIGRATION; INFANT; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; NEWBORN; NORTH AMERICA; PHENOTYPE; PRIORITY JOURNAL; AGE DISTRIBUTION; ETHNOLOGY; GENETICS; MIDDLE AGED; PRESCHOOL CHILD; THALASSEMIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; NORTH AMERICA; PHENOTYPE; THALASSEMIA;

EID: 33644701423     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0843     Document Type: Article

References (28)

1. Cooley TB, Lee P. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans Am Pediatr Soc. 1925;37:29
2. Whipple GH, Bradford WL. Racial or familial anemia of children: associated with fundamental disturbances of bone and pigment metabolism. Am J Med Sci. 1932;44:336
3. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79:704-712
4. Heer N, Choy J, Vichinsky EP. The social impact of migration on disease: Cooley's anemia, thalassemia, and new Asian immigrants. Ann N Y Acad Sci. 1998;850:509-511
5. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355:2051-2052
6. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994;331:567-573
7. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994;331:574-578
8. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227-231
9. Porter JB, Davis BA. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol. 2002;15:329-368
10. de Silva S, Fisher CA, Premawardhena A, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet. 2000;355:786-791
11. Clarke GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem. 2000;46(8 pt 2):1284-1290
12. Pearson HA, Guiliotis DK, O'Brien RT, McIntosh LS, Aspnes GT. Thalassemia in Greek Americans. J Pediatr. 1975;86:917-918
13. Pearson HA, Guiliotis DK, Rink L, Wells JA. Patient age distribution in thalassemia major: changes from 1973 to 1985. Pediatrics. 1987;80:53-57
14. Pearson HA, Cohen AR, Giardina PJ, Kazazian HH. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades. Pediatrics. 1996;97:352-356
15. Thein SL, Hesketh C, Taylor P, et al. Molecular basis for dominantly inherited inclusion body beta-thalassemia. Proc Natl Acad Sci USA. 1990;87:3924-3928
16. US Department of Homeland Security. Yearbook of Immigration Statistics, 2003. Washington, DC: US Government Printing Office; 2004
17. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001;2:245-255
18. Lorey F. Asian immigration and public health in California: thalassemia in newborns in California. J Pediatr Hematol Oncol. 2000;22:564-566
19. Whipple GH, Bradford WL. Mediterranean disease: thalassemia (erythroblastic anemia of Cooley). J Pediatr. 1936;9:279-311
20. Weatherall DJ. Introduction to the problem of hemoglobin E-beta thalassemia. J Pediatr Hematol Oncol. 2000;22:551
21. Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Test. 2001;5:93-100
22. Fouladi M, Macmillan ML, Nisbet-Brown E, et al. Hemoglobin E/beta thalassemia: the Canadian experience. Ann N Y Acad Sci. 1998;850:410-411
23. Styles LA. Hemoglobin H-Constant Spring disease: an under recognized, severe form of a thalassemia. J Pediatr Hematol Oncol. 1997;4:69-74
24. Singer ST, Styles L, Bojanowski J, Quirolo K, Foote D, Vichinsky EP. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol. 2000;22:539-542
25. Wang W, Kham SK, Yeo GH, Quah TC, Chong SS. Multiplex mini-sequencing screen for common Southeast Asian and Indian beta-thalassemia mutations. Clin Chem. 2003;49:209-218
26. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108:295-299
27. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood. 2000;95:360-362
28. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. Hematology (Am Soc Hematol Educ Program). 2004:14-34